Global Rna Analysis Market

RNA Analysis Market Size, Share, Growth Analysis, By Technology(Real Time-PCR (qPCR) Technology, Microarray Technology), By Product(Instruments, Kits & Reagents), By Application(Construction of RNA Expression Atlas, Epigenetics) - Industry Forecast 2024-2031


Report ID: SQMIG35H2192 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 100 | Figures: 76

RNA Analysis Market Insights

Global RNA Analysis Market size was valued at USD 15.5 billion in 2022 and is poised to grow from USD 16.12 billion in 2023 to USD 22.06 billion by 2031, growing at a CAGR of 4.00% during the forecast period (2024-2031).

The market is being driven by the increasing adoption of mineral supplements for managing chronic conditions due to a significant portion of the population grappling with diseases like cancer, osteoporosis, anemia, and osteoporosis. Major pharmaceutical firms are conducting social campaigns to encourage healthier lifestyles and supplement usage. For example, in February 2023, Torrent Pharmaceuticals Ltd unveiled a TV campaign named #BeShelcalStrong, aimed at boosting awareness about calcium deficiency and its impacts on daily life.

The upsurge in sedentary lifestyles and consumption of unhealthy diets has resulted in a higher number of people experiencing nutritional deficiencies. Proper body functioning requires varying mineral proportions. Insufficient minerals can lead to problems like fatigue, weak bones, and a compromised immune system. According to NutraIngredients-USA data, iron deficiency is most prevalent in the U.S. population. Additionally, government initiatives promoting healthier lifestyles are further stimulating market growth.

Beyond increased awareness about mineral supplement benefits, key market players are concentrating on inventive product development and exploring exotic ingredients. The rising popularity of plant-based products is also creating growth opportunities. Furthermore, for managing metabolic disorders, consumers are turning to personalized preventive products and services, favoring them over solely curative health practices, thereby fostering market growth.

In contrast to other sectors, the COVID-19 pandemic boosted the demand for mineral supplements. Research from the National Center for Biotechnology Information showed that the infection disproportionately affected individuals with mineral deficiencies. Recent studies propose that higher-than-recommended doses of mineral supplements could aid COVID-19 patients in reducing viral load and hospitalization. Consequently, this surge in demand prompted the introduction of new products. Nonetheless, counterfeit product sales are projected to impede market growth. Economic crises and political conflicts disrupt the supply chain, leading to an increase in locally produced, inexpensive items. Escalating demand and easy availability of mineral supplements have contributed to the proliferation of counterfeit goods.

US RNA Analysis Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

RNA Analysis Market size was valued at USD 15.5 billion in 2022 and is poised to grow from USD 16.12 billion in 2023 to USD 22.06 billion by 2031, growing at a CAGR of 4.00% during the forecast period (2024-2031).

The competitive landscape of the RNA analysis market is characterized by intense rivalry among established players and innovative entrants, all striving to carve a niche in this rapidly evolving domain. Major companies such as Thermo Fisher Scientific, Illumina, Inc., Agilent Technologies, and Qiagen AG dominate the market with their extensive product portfolios, advanced RNA sequencing platforms, and robust bioinformatics solutions. 'Thermo Fisher Scientific Inc. (USA)', 'Illumina, Inc. (USA)', 'Agilent Technologies, Inc. (USA)', 'Qiagen AG (Germany)', 'PerkinElmer, Inc. (USA)', 'Eurofins Scientific SE (Luxembourg)', 'Genewiz (a Brooks Life Sciences Company) (USA)', 'Bio-Rad Laboratories, Inc. (USA)', 'Merck KGaA (Germany)', 'Promega Corporation (USA)', 'Fluidigm Corporation (USA)', 'Oxford Nanopore Technologies Ltd. (United Kingdom)', 'Takara Bio Inc. (Japan)', 'Zymo Research Corporation (USA)', 'BGI Group (China)', 'NuGEN Technologies, Inc. (USA)', 'Lexogen GmbH (Austria)', 'Pacific Biosciences of California, Inc. (USA)', 'Roche Diagnostics (Switzerland)', 'Bio-Techne Corporation (USA)'

The pharmaceutical and biotech sectors heavily rely on RNA analysis to develop targeted therapies, personalized medicine, and innovative drug candidates. This has fueled substantial demand for RNA analysis techniques.

Long Read Sequencing: Advances in long-read sequencing technologies are enabling the accurate sequencing of full-length RNA molecules, enhancing the understanding of alternative splicing, isoforms, and complex gene structures.

In the year 2022, North America secured the largest market share, encompassing 44.10% of the total. This dominance can be attributed to the swift evolution of structure-based drug designs, an escalating emphasis on transcriptomics research, and substantial investments in biopharmaceutical research and development. Moreover, the pronounced uptick in financial allocations for pharmaceutical exploration and drug innovation significantly propels revenue growth for companies operating within this region. This dynamic landscape is fueled by the convergence of research and development initiatives, culminating in an amplified market presence.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Rna Analysis Market

Product ID: SQMIG35H2192

$5,300
BUY NOW GET FREE SAMPLE